The therapeutic misconception, beneficence, and respect
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Accountability in Research
- Vol. 8 (4) , 331-348
- https://doi.org/10.1080/08989620108573984
Abstract
In order to provide benefits to society, human medical trials must place subjects at risk of harm. This activity is thought to be justified in part by the consent of the subjects involved. But, studies have shown that most such consents are based on a therapeutic misconception (TM); the false belief of subjects that their researchers will act as their personal physicians (seeking their benefit and protecting them from harm), rather than placing them at risk of harm for the good of others. Toleration by researchers of the TM in their subjects is a form of “informational manipulation”; that renders consent procedures disrespectful to subject autonomy. Consent obtained from subjects who labor under a TM is neither voluntary nor informed; as long as they have not been disabused of the TM, the action they take in enrolling in a trial is not the one they intend nor is it autonomously chosen. Changes in consent procedures should be adopted to ensure that all subjects are aware inter alia that (a) the health interests of future patients (as well as the researchers’ and their sponsors’ financial interests) may be more important to researchers than the interest of a subject in his or her health, and (b) normal subjects neither understand nor believe this when told. Close attention to the response of prospective subjects to this information should allow for the exclusion of all but the truly altruistic. However, the result of conscientious implementation of such policies would likely be that human medical research could no longer be conducted on more than a minimal level.Keywords
This publication has 16 references indexed in Scilit:
- Panel Proposes Rules for Research AbroadScience, 2000
- Ethical and Human-Rights Issues in Research on Mental Disorders That May Affect Decision-Making CapacityNew England Journal of Medicine, 1999
- A review of patient outcomes in pharmacological studies from the psychiatric literature, 1966-1993.Science and Engineering Ethics, 1997
- Ethical Concerns About Relapse StudiesCambridge Quarterly of Healthcare Ethics, 1996
- COMMUNITY‐EQUIPOISE AND THE ETHICS OF RANDOMIZED CLINICAL TRIALSBioethics, 1995
- Equipoise and the Ethics of Clinical ResearchNew England Journal of Medicine, 1987
- The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequencesActa Psychiatrica Scandinavica, 1983
- Attitudes toward clinical trials among patients and the publicJAMA, 1982
- Informed consent to biomedical research in Veterans Administration HospitalsJAMA, 1982
- A depot neuroleptic withdrawal studyActa Psychiatrica Scandinavica, 1981